The impact of the Covid-19-Pandemic on patients in DMP diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025333

Enrollment

128

Registered

2021-05-25

Start date

2021-06-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11

Interventions

Group 1: Retrospectively: Extraction of three blood samples in the 1st, 2nd and 3rd quarter of the year 2020. These values were extracted routinely in the Disease-Management-Programme Diabetes (DMP Di

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - legal age, legal competence - patients with type 2 diabetes that take part in the DMP - Enlightenment and presence of a written consent

Exclusion criteria

Exclusion criteria: - missing consent - patents that are suffering from diabetes, but are not enrolled in the DMP - Patients that sickened from Covid-19

Design outcomes

Primary

Measure	Time frame
Routinely, blood samples were extracted framed in the DMP between January 2020 and September 2020 and the HbA1c value was defined.	—

Secondary

Measure	Time frame
The definition of cholesterol, LDL-Cholesterol, HDL-Cholesterol and Trigyceride took place routinely with the extraction of blood samples between January 2020 and September 2020. Additionally, weight and blood pressure were defined.	—

Countries

Germany

Contacts

Public ContactMaximilian Alt

Praxis Dr. Alt

max1987_14@hotmail.com063827412

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026